Madan Jagasia

Madan Jagasia

UNVERIFIED PROFILE

Are you Madan Jagasia?   Register this Author

Register author
Madan Jagasia

Madan Jagasia

Publications by authors named "Madan Jagasia"

Are you Madan Jagasia?   Register this Author

100Publications

3435Reads

27Profile Views

Ibrutinib for Chronic Graft-versus-Host Disease After Failure of Prior Therapy: 1-Year Update of a Phase 1b/2 Study.

Biol Blood Marrow Transplant 2019 Oct 28;25(10):2002-2007. Epub 2019 Jun 28.

Division of Hematology, Department of Internal Medicine, The Ohio State University Medical Center, Columbus, Ohio.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2019.06.023DOI Listing
October 2019

Organ Changes Associated with Provider-Assessed Responses in Patients with Chronic Graft-versus-Host Disease.

Biol Blood Marrow Transplant 2019 Sep 11;25(9):1869-1874. Epub 2019 May 11.

Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington; Department of Medicine, University of Washington, Seattle, Washington.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2019.05.008DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6755054PMC
September 2019

The Chronic Graft-versus-Host Disease Failure-Free Survival (cGVHD-FFS) Index.

Biol Blood Marrow Transplant 2019 Aug 5. Epub 2019 Aug 5.

Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington; Department of Medicine, University of Washington, Seattle, Washington. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2019.07.040DOI Listing
August 2019

Crowdsourcing to delineate skin affected by chronic graft-vs-host disease.

Skin Res Technol 2019 Jul 20;25(4):572-577. Epub 2019 Feb 20.

Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, Tennessee.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/srt.12688DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6719554PMC
July 2019

Non-invasive measurement of sclerosis in cutaneous cGVHD patients with the handheld device Myoton: a cross-sectional study.

Bone Marrow Transplant 2019 Apr 4;54(4):616-619. Epub 2018 Oct 4.

Department of Dermatology, Vanderbilt University Medical Center, Nashville, TN, USA.

View Article

Download full-text PDF

Source
http://www.nature.com/articles/s41409-018-0346-7
Publisher Site
http://dx.doi.org/10.1038/s41409-018-0346-7DOI Listing
April 2019

Registries and artificial intelligence: investing in the future of hematopoietic cell transplantation.

Bone Marrow Transplant 2019 Mar 31;54(3):477-480. Epub 2018 Aug 31.

Oncology Center, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.

View Article

Download full-text PDF

Source
http://www.nature.com/articles/s41409-018-0327-x
Publisher Site
http://dx.doi.org/10.1038/s41409-018-0327-xDOI Listing
March 2019

Highlights in Graft-vs-Host Disease From the 60th American Society of Hematology Annual Meeting: Commentary.

Authors:
Madan Jagasia

Clin Adv Hematol Oncol 2019 Mar;17 Suppl 6(3):16-18

Vanderbilt University Medical Center, Vanderbilt-Ingram Cancer Center, Nashville, Tennessee.

View Article

Download full-text PDF

Source
March 2019

The Anatomic Distribution of Skin Involvement in Patients with Incident Chronic Graft-versus-Host Disease.

Biol Blood Marrow Transplant 2019 02 13;25(2):279-286. Epub 2018 Sep 13.

Department of Veterans Affairs Tennessee Valley Healthcare System, Nashville, Tennessee; Vanderbilt University School of Medicine, Nashville, Tennessee; Department of Dermatology, Vanderbilt University Medical Center, Nashville, Tennessee; Department of Biomedical Engineering, Vanderbilt University, Nashville, Tennessee. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2018.09.007DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6546305PMC
February 2019

A Prospective Trial of Extracorporeal Photopheresis for Chronic Graft-versus-Host Disease Reveals Significant Disease Response and No Association with Frequency of Regulatory T Cells.

Biol Blood Marrow Transplant 2018 12 5;24(12):2373-2380. Epub 2018 Jul 5.

Department of Hematology/Oncology, Vanderbilt University Medical Center, Nashville, Tennessee. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2018.06.035DOI Listing
December 2018

Impact of Psychological Distress on Quality of Life, Functional Status, and Survival in Patients with Chronic Graft-versus-Host Disease.

Biol Blood Marrow Transplant 2018 11 20;24(11):2285-2292. Epub 2018 Jul 20.

Department of Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S10838791183040
Publisher Site
http://dx.doi.org/10.1016/j.bbmt.2018.07.020DOI Listing
November 2018

Defining Incidence and Risk Factors for Catheter-Associated Bloodstream Infections in an Outpatient Adult Hematopoietic Cell Transplantation Program.

Biol Blood Marrow Transplant 2018 10 9;24(10):2081-2087. Epub 2018 May 9.

Division of Infectious Diseases, Department of Internal Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2018.04.031DOI Listing
October 2018

Outcomes of a novel rituximab-based non-myeloablative conditioning regimen for hematopoietic cell transplantation in severe aplastic anemia.

Bone Marrow Transplant 2018 06 14;53(6):795-799. Epub 2018 Mar 14.

Division of Hematology/Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41409-018-0124-6DOI Listing
June 2018

Ruxolitinib for the treatment of patients with steroid-refractory GVHD: an introduction to the REACH  trials.

Immunotherapy 2018 04 10;10(5):391-402. Epub 2018 Jan 10.

Department of Hematology, Oncology & Stem Cell Transplantation, University Hospital Freiburg, Hugstetter Str. 55, 79106 Freiburg im Breisgau, Germany.

View Article

Download full-text PDF

Source
https://www.futuremedicine.com/doi/10.2217/imt-2017-0156
Publisher Site
http://dx.doi.org/10.2217/imt-2017-0156DOI Listing
April 2018

Reply to J.J. Boelens et al.

J Clin Oncol 2018 04 7;36(11):1176-1177. Epub 2018 Feb 7.

Robert J. Soiffer, Dana-Farber Cancer Institute, Boston, MA; Yi-Bin A. Chen, Massachusetts General Hospital, Boston, MA; and Madan H. Jagasia, Vanderbilt University Medical Center, Nashville, TN.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.77.2939DOI Listing
April 2018

Association of Socioeconomic Status with Chronic Graft-versus-Host Disease Outcomes.

Biol Blood Marrow Transplant 2018 02 12;24(2):393-399. Epub 2017 Oct 12.

Division of Hematology/Oncology, Vanderbilt University, Nashville, Tennessee. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2017.10.009DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5767523PMC
February 2018

Optimizing Antithymocyte Globulin Dosing for Unrelated Donor Allogeneic Hematopoietic Cell Transplantation Based on Recipient Absolute Lymphocyte Count.

Biol Blood Marrow Transplant 2018 01 30;24(1):150-155. Epub 2017 Aug 30.

Division of Hematology/Oncology, Stem Cell Transplantation, Department of Medicine, Vanderbilt University, Nashville, Tennessee.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2017.08.029DOI Listing
January 2018

Fludarabine and Busulfan versus Fludarabine, Cyclophosphamide, and Rituximab as Reduced-Intensity Conditioning for Allogeneic Transplantation in Follicular Lymphoma.

Biol Blood Marrow Transplant 2018 01 13;24(1):78-85. Epub 2017 Oct 13.

Division of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, Wisconsin; Center for International Blood and Marrow Transplant Research, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2017.10.011DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5743624PMC
January 2018

Prospective, Randomized, Double-Blind, Phase III Clinical Trial of Anti-T-Lymphocyte Globulin to Assess Impact on Chronic Graft-Versus-Host Disease-Free Survival in Patients Undergoing HLA-Matched Unrelated Myeloablative Hematopoietic Cell Transplantation.

J Clin Oncol 2017 Dec 17;35(36):4003-4011. Epub 2017 Oct 17.

Robert J. Soiffer, Haesook T. Kim, Vincent T. Ho, Edwin P. Alyea, and Jerome Ritz, Dana-Farber Cancer Institute; James D. Levine, Beth Israel Deaconess Medical Center and Harvard Medical School; Yi-Bin Chen, Massachusetts General Hospital, Boston; Frank Glavin, Neovii Biotech, Lexington, MA; Joseph McGuirk, University of Kansas Medical Center, Kansas City, KS; Mitchell E. Horwitz, Duke University Medical Center, Durham; Thomas C. Shea, University of North Carolina School of Medicine, Chapel Hill, NC; Laura Johnston, Stanford University, Stanford, CA; Mrinal M. Patnaik, Mayo Clinic, Rochester, MN; Witold Rybka, Penn State College of Medicine, Hershey; David L. Porter, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA; Andrew Artz, University of Chicago, Chicago; Patrick J. Stiff, Loyola University Medical Center, Maywood, IL; Michael W. Boyer, University of Utah, Salt Lake City, UT; Richard T. Maziarz, Oregon Health & Science University, Portland, OR; Paul J. Shaughnessy, Texas Transplant Institute, San Antonio; Madhuri Vusirikala, University of Texas Southwestern Medical Center, Dallas, TX; Usama Gergis, Weill Cornell Medical College; Ran Reshef, Columbia University Medical Center, New York, NY; Hana Safah, Tulane University, New Orleans, LA; John F. DiPersio and Peter Westervelt, Washington University School of Medicine, St Louis, MO; Jeff Szer, Royal Melbourne Hospital, Parkville, Victoria; Ian D. Lewis, Royal Adelaide Hospital, Adelaide, South Australia, Australia; Jennifer Holter, University of Oklahoma Health Sciences Center, Oklahoma City, OK; Paul J. Martin, Fred Hutchinson Cancer Research Center, Seattle, WA; Joseph A. Pidala, H. Lee Moffitt Cancer Center, Tampa, FL; and Madan H. Jagasia, Vanderbilt University Medical Center, Nashville, TN.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.75.8177DOI Listing
December 2017

Comparison of BCR/ABL1 mRNA levels by quantitative real-time PCR in peripheral blood and bone marrow specimens of patients with chronic myelogenous leukemia.

Leuk Lymphoma 2017 09 14;58(9):1-4. Epub 2017 Feb 14.

c Department of Pathology, Microbiology and Immunology and Pediatrics , Vanderbilt University Medical Center , Nashville , TN , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2017.1287362DOI Listing
September 2017

Validation of International Chronic Ocular Graft-Versus-Host Disease (GVHD) Group Diagnostic Criteria as a Chronic Ocular GVHD-Specific Metric.

Cornea 2017 Feb;36(2):258-263

*Vanderbilt Eye Institute, Vanderbilt University School of Medicine, Nashville, TN; †Massachusetts Eye and Ear Infirmary, Massachusetts General Hospital, Boston, MA; ‡Department of Medicine, Division of Hematology/Oncology, Vanderbilt University School of Medicine, Nashville, TN; and §Department of Biostatistics, Vanderbilt University School of Medicine, Nashville, TN.

View Article

Download full-text PDF

Source
http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:land
Publisher Site
http://dx.doi.org/10.1097/ICO.0000000000001109DOI Listing
February 2017

NCCN Guidelines Insights: Chronic Myeloid Leukemia, Version 1.2017.

J Natl Compr Canc Netw 2016 12;14(12):1505-1512

From St. Jude Children's Research Hospital/The University of Tennessee Health Science Center; Robert H. Lurie Comprehensive Cancer Center of Northwestern University; Memorial Sloan Kettering Cancer Center; Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine; The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute; UC San Diego Moores Cancer Center; Dana-Farber/Brigham and Women's Cancer Center; Stanford Cancer Institute; Fred & Pamela Buffett Cancer Center; Massachusetts General Hospital Cancer Center; Vanderbilt-Ingram Cancer Center; The University of Texas MD Anderson Cancer Center; Fox Chase Cancer Center; Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute; Duke Cancer Institute; Roswell Park Cancer Institute; University of Colorado Cancer Center; University of Michigan Comprehensive Cancer Center; University of Alabama at Birmingham Comprehensive Cancer Center; Yale Cancer Center/Smilow Cancer Hospital; UCSF Helen Diller Family Comprehensive Cancer Center; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; City of Hope Comprehensive Cancer Center; Moffitt Cancer Center; Mayo Clinic Cancer Center; University of Wisconsin Carbone Cancer Center; National Comprehensive Cancer Network; Huntsman Cancer Institute at the University of Utah; and Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.6004/jnccn.2016.0162DOI Listing
December 2016

Reduced-Intensity Conditioning with Fludarabine, Cyclophosphamide, and Rituximab Is Associated with Improved Outcomes Compared with Fludarabine and Busulfan after Allogeneic Stem Cell Transplantation for B Cell Malignancies.

Biol Blood Marrow Transplant 2016 10 1;22(10):1801-1807. Epub 2016 Jul 1.

Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee; Division of Hematology/Oncology, Stem Cell Transplantation, Department of Medicine, Vanderbilt University, Nashville, Tennessee.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2016.06.029DOI Listing
October 2016

Biomarker Panel for Chronic Graft-Versus-Host Disease.

J Clin Oncol 2016 08 23;34(22):2583-90. Epub 2016 May 23.

Jeffrey Yu, Kushi Kushekhar, Mohammad Abu Zaid, and Sophie Paczesny, Indiana University School of Medicine, Indianapolis, IN; Barry E. Storer, Paul J. Martin, Mary E. Flowers, John A. Hansen, Stephanie J. Lee, Qing Zhang, Philip R. Gafken, and Yuko Ogata, Fred Hutchinson Cancer Research Center; Barry E. Storer, University of Washington School of Medicine, Seattle, WA; Mukta Arora, University of Minnesota, Minneapolis, MN; Corey Cutler, Dana-Farber Cancer Institute, Boston, MA; Madan Jagasia, Vanderbilt University, Nashville, TN; Joseph Pidala, H. Lee Moffitt Cancer Center, Tampa, FL; Betty K. Hamilton, Cleveland Clinic Foundation, Cleveland, OH; George L. Chen, Roswell Park Cancer Institute, Buffalo, NY; and Iskra Pusic, Washington University School of Medicine, St Louis, MO.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.65.9615DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5012688PMC
August 2016

Early Th1 immunity promotes immune tolerance and may impair graft-versus-leukemia effect after allogeneic hematopoietic cell transplantation.

Haematologica 2016 05 27;101(5):e204-8. Epub 2016 Jan 27.

Department of Pediatrics, Vanderbilt University Medical Center, Nashville, TN, USA Department of Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN, USA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3324/haematol.2015.139501DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5004357PMC
May 2016

Cardiovascular Complications of Novel Multiple Myeloma Treatments.

Circulation 2016 Mar;133(9):908-12

From Department of Medicine, Jacobi Medical Center, Albert Einstein College of Medicine, New York, NY(W.L.); Division of Hematology and Oncology, Department of Internal Medicine, Vanderbilt University Medical Center, Nashville, TN(R.F.C., M.J., J.M.), Cardiovascular Division(D.L., D.S., J.M.) and Cardio-Oncology Program(D.L., D.S., J.M.), Vanderbilt University School of Medicine, Nashville, TN; and Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA(G.P.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCULATIONAHA.115.018351DOI Listing
March 2016

When Can You Discard Stem Cells?

Biol Blood Marrow Transplant 2015 Nov 4;21(11):2033. Epub 2015 Aug 4.

Hematology and Stem Cell Transplantation Section, Division of Hematology/Oncology, Department of Medicine, Vanderbilt University Medical Center and Veterans Affairs Medical Center, Nashville, Tennessee.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2015.07.024DOI Listing
November 2015

Impact of Ocular Chronic Graft-versus-Host Disease on Quality of Life.

Biol Blood Marrow Transplant 2015 Sep 30;21(9):1687-91. Epub 2015 May 30.

Division of Hematology/Oncology, Stem Cell Transplantation, Department of Medicine, Vanderbilt University, Nashville, Tennessee. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2015.05.020DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4537831PMC
September 2015

Quality of Life in the Chronic GVHD Consortium Cohort: Lessons Learned and the Long Road Ahead.

Curr Hematol Malig Rep 2015 Sep;10(3):183-91

Pediatric Hematology/Oncology, Monroe Carell Jr. Children's Hospital at Vanderbilt, Vanderbilt University Medical Center, 397 PRB, 2220 Pierce Avenue, Nashville, TN, 37232-6310, USA,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11899-015-0265-2DOI Listing
September 2015

Referral to transplant center for hematopoietic cell transplantation.

Hematol Oncol Clin North Am 2014 Dec 26;28(6):1201-13. Epub 2014 Sep 26.

Division of Hematology-Oncology, Vanderbilt University Medical Center, 3973 TVC, Nashville, TN 37232, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.hoc.2014.08.007DOI Listing
December 2014

Impact of age on quality of life, functional status, and survival in patients with chronic graft-versus-host disease.

Biol Blood Marrow Transplant 2014 Sep 9;20(9):1341-8. Epub 2014 May 9.

Division of Bone Marrow Transplantation, Massachusetts General Hospital Cancer Center, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2014.05.001DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4127362PMC
September 2014

Outcomes of autologous or allogeneic stem cell transplantation for non-Hodgkin lymphoma.

Exp Hematol 2014 Jan 2;42(1):39-45. Epub 2013 Oct 2.

Hematology and Stem Cell Transplantation Section, Division of Hematology/Oncology, Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.exphem.2013.09.012DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5002948PMC
January 2014

Geographic distance is not associated with inferior outcome when using long-term transplant clinic strategy.

Biol Blood Marrow Transplant 2014 Jan 10;20(1):53-7. Epub 2013 Oct 10.

Division of Hematology/Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2013.10.004DOI Listing
January 2014

Chronic Myelogenous Leukemia, Version 1.2014.

J Natl Compr Canc Netw 2013 Nov;11(11):1327-40

From 1The University of Texas MD Anderson Cancer Center; 2Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance; 3Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine; 4Fred & Pamela Buffett Cancer Center at The Nebraska Medical Center; 5Robert H. Lurie Comprehensive Cancer Center of Northwestern University; 6Memorial Sloan-Kettering Cancer Center; 7Dana-Farber/Brigham & Women's Cancer Center; 8Huntsman Cancer Institute at the University of Utah; 9The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute; 10Massachusetts General Hospital Cancer Center; 11Stanford Cancer Institute; 12Vanderbilt-Ingram Cancer Center; 13Fox Chase Cancer Center; 14Duke Cancer Institute; 15St. Jude Children's Research Hospital/The University of Tennessee Health Science Center; 16Moffitt Cancer Center; 17University of Alabama at Birmingham Comprehensive Cancer Center; 18UCSF Helen Diller Family Comprehensive Cancer Center; 19The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; 20City of Hope Comprehensive Cancer Center; 21Roswell Park Cancer Institute; and 22National Comprehensive Cancer Network.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4234105PMC
http://dx.doi.org/10.6004/jnccn.2013.0157DOI Listing
November 2013

New allergies after cord blood transplantation.

Cytotherapy 2013 Oct;15(10):1259-65

Hematology and Stem Cell Transplantation Section, Division of Hematology/Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcyt.2013.05.018DOI Listing
October 2013

Tissue-specific regulatory T cells: biomarker for acute graft-vs-host disease and survival.

Exp Hematol 2012 Dec 10;40(12):974-982.e1. Epub 2012 Aug 10.

Department of Medicine, Vanderbilt University Medical Center, Nashville, TN 37232-2905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.exphem.2012.08.002DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3611587PMC
December 2012

Superior long-term outcome of patients with early transformation of non-Hodgkin lymphoma undergoing stem cell transplantation.

Clin Lymphoma Myeloma Leuk 2012 Dec 14;12(6):406-11. Epub 2012 Sep 14.

Hematology and Stem Cell Transplantation Section, Division of Hematology/Oncology, Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN 37232, USA.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S215226501200136
Publisher Site
http://dx.doi.org/10.1016/j.clml.2012.07.003DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4845749PMC
December 2012